Introduction
============

*Salmonella enterica* is a leading cause of bacterial foodborne infections worldwide that can induce from enterocolitis to systemic diseases, depending on the serovar-host combination ([@B15]). The broad-host-range serovar Typhimurium causes gastroenteritis in humans, calves and other animals, but it causes a systemic typhoid fever-like disease in susceptible mouse strains ([@B69]; [@B70]). The virulence of these bacteria relies on the possession of specific genes. Many of them are horizontally transferred elements that are clustered in *Salmonella* pathogenicity islands (SPIs; [@B31]). The biggest and best studied clusters are SPI1 and SPI2, which encode two type III secretion systems, T3SS1 and T3SS2, that are important for invasion of non-phagocytic cells and for intracellular survival and proliferation, respectively ([@B22]; [@B58]; [@B66]). These are flagellum-like one-step transport systems that carry out translocation of proteins, known as effectors, across the two membranes of Gram-negative bacteria and the host cell membrane.

More than 30 effectors are secreted through *Salmonella* T3SSs ([@B60]; [@B32]). Some of them are encoded in SPI1 or SPI2 but many are encoded outside the islands. The best characterized *Salmonella* invasion mechanism, the "trigger" mechanism, requires at least six T3SS1 effectors, SipA, SipC, SopB, SopE, SopE2, and SptP, that induce remodeling of actin cytoskeleton ([@B30]). SipA, SopB, SopE, and SopE2 are also involved in the disruption of epithelial tight junctions ([@B7]), whereas AvrA is a tight junction stabilizer ([@B43]). SopA, another T3SS1 effector, is involved in *Salmonella*-induced polymorphonuclear leukocytes transepithelial migration ([@B74]). Other processes where T3SS1 is involved are the early and intermediate stages of the *Salmonella*-containing vacuole (SCV) biogenesis ([@B5]; [@B67]), and the induction of a rapid form of pyroptosis, a caspase-1 dependent form of programmed cell death, in macrophages ([@B21]). T3SS2 is expressed intracellularly in response to the low pH and nutrient concentration found in the lumen of the SCV. This system translocates more than 20 effectors through the SCV membrane and is involved in several processes including intermediate and late stages of the SCV biogenesis, generation of tubular networks ([@B64]), apoptosis in epithelial cells, and delayed pyroptosis in macrophages ([@B21]).

According to the different predominant functions related to T3SS1 and T3SS2, the conditions for optimal expression of SPI1 or SPI2 are reached at different moments of the infection. These conditions can be modeled *in vitro* using appropriate media: rich medium with low aeration and high NaCl concentration for SPI1, and minimal medium with low pH and low Mg^2+^ concentration for SPI2. Some effectors are specifically coexpressed with their cognate T3SS. There are, however, other effectors that are expressed under a broad range of conditions and can be secreted through both systems. This has been described for GtgE ([@B57]), PipB2 ([@B2]), SlrP ([@B50]; [@B18]), SopD ([@B37]; [@B9]), SpvC ([@B48]; [@B34]), SpvD ([@B57]), SspH1 ([@B51]), SteA ([@B12]), and SteE ([@B57]).

SseK1 was identified in *S. enterica* serovar Typhimurium as a T3SS substrate because of its similarity to known secreted proteins from enterohemorrhagic *Escherichia coli* and *Citrobacter rodentium* ([@B41]). Translocation of this protein into epithelial cells was shown to be T3SS2-dependent and after translocation SseK1 localized to the host cytosol. At least two paralogs exist in some *S. enterica* serovars or strains: SseK2 ([@B41]), which shares 61% amino acid sequence identity with SseK1, and SseK3 ([@B8]), which is encoded in a prophage and is 75% identical to SseK2. Because of their striking similarity they are considered members of the same effector family and they are predicted to have redundant functions. However, the specific roles of these proteins in the host cells are unknown and there are conflicting reports about their relevance for intracellular replication of *Salmonella* and for virulence in mice. A study of the contribution of some T3SS2 effectors to replication in host cells reported that a triple mutant *sseK1 sseK2 sseK3* had significantly reduced growth levels in RAW264.7 macrophages but showed no defect in bacterial counts in systemic organs of mice after oral infection ([@B10]). In contrast, another study showed significant attenuation for this mutant in mice but did not detect intracellular growth defects ([@B8]).

In this work, we carry out a detailed analysis of the patterns of expression and the kinetics of translocation of SseK1 into different host cell models. Our data suggest that, under physiological conditions of expression, SseK1 is not translocated upon the initial contact with the eukaryotic cell but when *Salmonella* is inside the cell. Interestingly, translocation can occur through T3SS1 and/or T3SS2, depending of the host cell type and the time after infection. We also show an SsrB-independent, positive, direct regulation of *sseK1* by the two-component system PhoQ/PhoP and identify a PhoP box in the promoter region of SseK1.

Materials and Methods {#s1}
=====================

Bacterial Strains, Bacteriophages and Strain Construction
---------------------------------------------------------

*Escherichia coli* and*S. enterica* serovar Typhimurium strains used in this study are described in **Table [1](#T1){ref-type="table"}**. *Salmonella* strains derive from the mouse-virulent strain ATCC 14028. Transductional crosses using phage P22 HT 105/1 *int201* ([@B63]) were used for strain construction ([@B47]). To obtain phage-free isolates, transductants were purified by streaking on green plates. Green plates were prepared as described ([@B14]), except that methyl blue (Sigma) substituted for aniline blue. Phage sensitivity was tested by cross-streaking with the clear-plaque mutant P22 H5 ([@B14]).

###### 

Bacterial strains and plasmids used in this study.

  Strain/plasmid                                         Relevant characteristics                                                                              Source/reference
  ------------------------------------------------------ ----------------------------------------------------------------------------------------------------- ------------------
  ***Escherichia coli***                                                                                                                                       
  DH5α                                                   *supE44 ΔlacU*169 (Ø80 *lacZΔ*M15) *hsdR17 recA1 endA1 gyrA96 thi-1 relA1*                            [@B33]
  XL1-Blue                                               *recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 Δlac-pro*/F' *proAB lacI^q^ lacZ*ΔM15 Tn*10* (Tet^r^)   [@B11]
  M15                                                    *lac ara gal mtl*                                                                                     Qiagen
  ***Salmonella enterica* serovar Typhimurium^**a**^**                                                                                                         
  14028                                                  Wild-type                                                                                             ATCC
  55130                                                  *phoQ24* (PhoP constitutive)                                                                          E. A. Groisman
  SV4536                                                 *Δdam-230*                                                                                            [@B59]
  SV4608                                                 *trg::*Mu*d*J                                                                                         [@B65]
  SV4699                                                 *phoP7953::*Tn10, Tc^r^                                                                               [@B29], [@B65]
  SV4757                                                 *rcsC54*                                                                                              [@B26]
  SV5049                                                 *ΔrcsB*::Cm^r^                                                                                        [@B25]
  SV5373                                                 *ΔhilA*                                                                                               J. López-Garrido
  SV5452                                                 *ΔssrB*::Cm^r^                                                                                        [@B25]
  SV6017                                                 *Δ*SPI2::Cm^r^                                                                                        [@B2]
  SV6055                                                 *Δ*SPI1::Km^r^                                                                                        [@B2]
  SV6402                                                 *ΔhilD*::Cm^r^                                                                                        J. López-Garrido
  SV7070                                                 *ΔsseK1*::Km^r^                                                                                       This study
  SV7071                                                 *sseK1::*3xFLAG, Km^r^                                                                                This study
  SV7179                                                 *ΔsseK1*                                                                                              This study
  SV7381                                                 *sseK1::cyaA',* Km^r^                                                                                 This study
  SV8165                                                 *sseK1::lacZ* (translational fusion)                                                                  This study
  **Plasmids**                                                                                                                                                 
  pCE36                                                  *aph* FRT *lacZY^+^* t*~his~* oriR6K                                                                  [@B20]
  pCE40                                                  *aph* FRT *'lacZ lacY^+^* t*~his~* oriR6K                                                             [@B20]
  pCP20                                                  *bla cat cI857* P~R~ *flp* pSC101 oriTS                                                               [@B16]
  pIC552                                                 parent for *lacZ* transcriptional fusions, Ap^r^                                                      [@B46]
  pIZ1673                                                pSIF003-R1 *ΔlacI*                                                                                    [@B12]
  pIZ1949                                                pQE30-*phoP*                                                                                          [@B13]
  pIZ1959                                                pIZ1673-SseK1(1-336)                                                                                  This study
  pIZ2095                                                pIC552- P*sseK1*(-500/+40)                                                                            This study
  pIZ2112                                                pIC552- P*sseK1*(-500/+40)TT-73/-72CC                                                                 This study
  pIZ2115                                                pSB377-P*sseK1*(-500/+40)                                                                             This study
  pIZ2135                                                pSB377-P*sseK1*(-500/+40)TT-51/-50CC                                                                  This study
  pIZ2136                                                pSB377-P*sseK1*(-500/+40)TT-62/-61CC                                                                  This study
  pIZ2137                                                pSB377-P*sseK1*(-500/+40)TT-73/-72CC                                                                  This study
  pIZ2154                                                pIC552- P*sseK1*(-500/+40)TT-62/-61, -73/-72CC                                                        This study
  pKD4                                                   *bla* FRT *aph* FRT PS1 PS2 oriR6K                                                                    [@B19]
  pKD13                                                  *bla* FRT *aph* FRT PS1 PS4 oriR6K                                                                    [@B19]
  pKD46                                                  *bla* P~BAD~ *gam bet exo* pSC101 oriTS                                                               [@B19]
  pREP4                                                  *lacI*, Km^r^                                                                                         Qiagen
  pSB377                                                 parent for *luxCDABE* transcriptional fusions, Ap^r^                                                  [@B72]

a

Derivatives of these strains were used as indicated in the text.

Bacterial Culture
-----------------

The standard culture medium for *S. enterica* and *E. coli* was Luria-Bertani (LB) broth. For SPI1-inducing conditions, *S. enterica* strains were grown overnight at 37°C in LB-0.3 M NaCl medium without shaking. For SPI2-inducing conditions, bacteria were inoculated in low magnesium minimal medium (LPM) at pH 5.8, and incubated overnight at 37°C with shaking. LPM contained 80 mM 2-(*N*-morpholino) ethanesulfonic acid (pH 5.8), 5 mM KCl, 7.5 mM (NH~4~)~2~SO~4~, 0.5 mM K~2~SO~4~, 0.1% casamino acids, 38 mM glycerol, 337.5 μM K~2~HPO~4~-KH~2~PO~4~ (pH 7.4), and 8 μM MgCl~2~. For some experiments the concentration of NaCl, of MgCl~2~, or the pH of the medium were modified as indicated. Solid media contained 1.5% agar. Antibiotics were used at the following final concentrations in rich medium: kanamycin (Km), 50 μg ml^-1^; chloramphenicol (Cm), 20 μg ml^-1^; ampicillin (Ap), 100 μg ml^-1^; tetracycline (Tc), 20 μg ml^-1^. In minimal medium antibiotics were used at these concentrations: kanamycin, 125 μg ml^-1^; chloramphenicol, 5 μg ml^-1^; ampicillin, 50 μg ml^-1^; tetracycline, 10 μg ml^-1^. Plates for monitoring β-galactosidase activity contained 5-bromo-4-chloro-indolyl-β-[D]{.smallcaps}-galactopyranoside (X-Gal, final concentration, 40 μg ml^-1^). 10 mM sodium butyrate (Sigma) was added to the medium in some experiments.

Mammalian Cell Culture
----------------------

HeLa (human epithelial; ECAC no. 93021013), RAW264.7 (murine macrophages; ECACC no. 91062702), NRK-49F (normal rat kidney fibroblasts; ATCC CRL-1570), Cos-7 (monkey fibroblasts; ATCC CRL-1651), NIH3T3 (murine fibroblasts; ATCC CRL-1658), J774A.1 (murine macrophages; ATCC TIB-67) and Caco2 (human epithelial; ATCC HTB-37) cells were cultured in DMEM supplemented with 10% fetal calf serum and 2 mM [L]{.smallcaps}-glutamine. Sixty μg ml^-1^ penicillin, and 100 μg ml^-1^ streptomycin were included in the culture media (except for bacterial infection experiments). All cells were maintained in a 5% CO~2~ humidified atmosphere at 37°C.

DNA Amplification with the Polymerase Chain Reaction and Sequencing
-------------------------------------------------------------------

Amplification reactions were carried out in a T100 Thermal Cycler (Bio-Rad). The final volume of reactions was 50 μl, and the final concentration of MgCl~2~ was 1.5 mM. Reagents were used at the following concentrations: dNTPs, 300 μM; primers, 0.3 μM; and Taq polymerase (KAPA HiFi DNA Polymerase, Kapa Biosystems), 1 unit per reaction. The thermal program included the following steps: (i) initial denaturation, 3 min at 95°C; (ii) 25 cycles of denaturation (98°C, 20 s), annealing (60°C, 15 s), and extension (72°C, 30 s per kb); and (iii) final incubation at 72°C for 5 min, to complete extension. To generate directed mutations in the *sseK1* promoter cloned in pSB377 or pIC552 the thermal program included the following steps: (i) initial denaturation, 3 min at 95°C; (ii) 17 cycles of denaturation (98°C, 20 s), annealing (62°C, 15 s), and extension (72°C, 6 min); (iii) final extension at 72°C for 5 min. Primers are listed in **Table [2](#T2){ref-type="table"}**. PCR constructs were sequenced with an automated DNA sequencer (Stab Vida, Oeiras, Portugal).

###### 

Oligonucleotides used in this study.

  -----------------------------------------------------------------------------------------------
  Oligonucleotide/use                                      Sequence 5′-3′
  -------------------------------------------------------- --------------------------------------
  ***sseK1* deletion**                                     

  sseK1dP1                                                 TAAAATATGTAATGAAGTAAGTATGGAGCA\
                                                           TTTAATTGTTGTGTAGGCTGGAGCTGCTTC

  sseK1dP2                                                 ATATTTTATGTATTCAATAGCATGATTATTGCCA\
                                                           TTTCCGCATATGAATATCCTCCTTAG

  **Construction of *sseK1::lacZ* translational fusion**   

  sseK1P1b                                                 CATGAACTTTGCGTAAACTGACTGGTATTCATT\
                                                           ATAATGTGTGTAGGCTGGAGCTGCTTC

  sseK1P4                                                  ATATGTTCCCGCGCTTTCAAAAAATGAATTGGTT\
                                                           AAAACTATTCCGGGGATCCGTCGACC

  **Epitope tagging of SseK1**                             

  sseK1P1flag                                              CAGTCAGTTTACGCAAAGTTCATGGGCGAGGCAT\
                                                           GTGCAGGACTACAAAGACCATGACGG

  sseK1P2flag                                              ATATTTTATGTATTCAATAGCATGATTATTGC\
                                                           CATTTCCGCATATGAATATCCTCCTTAG

  **Chromosomal *sseK1::cyaA'* fusion**                    

  sseK1P1                                                  CAGTCAGTTTACGCAAAGTTCATGGGCGAGGCA\
                                                           TGTGCAGCTGCAGCAATCGCATCAGGC

  sseK1P2                                                  ATATTTTATGTATTCAATAGCATGATTATTGCCAT\
                                                           TTCCGTTAGAAAAACTCATCGAGCATC

  **Verification of chromosomal *sseK1::cyaA'* fusion**    

  sseK1E1                                                  TTAATTGCTCACTGGCAGGG

  sseK1E2                                                  GCACTGCGATTTTAAAGTGG

  cyaArev                                                  CCTTGATGCCATCGAGTACG

  **Construction of pIZ1959**                              

  sseK1BampSIFfw                                           AGTCGGATCCAGGAGGAAATAT\
                                                           ATGATCCCACCATTAAATAG

  sseK1BampSIFrev                                          GATCGGATCCACTGCACATG\
                                                           CCTCGCCCATG

  **Construction of pIZ2095**                              

  PsseK1-500fwBgl                                          AGTCAGATCTTTGGGACAATTACATTATG

  PsseK1+40revXho                                          AGTCCTCGAGAACAATTAAATGCTCCATAC

  **Construction of pIZ2115**                              

  PsseK1-500fwEco                                          AGTCGAATTCTTGGGACAATTACATTATG

  PsseK1+40revEco                                          AGTCGAATTCAACAATTAAATGCTCCATAC

  **Construction of pIZ2135**                              

  sseK1TT-51CCfw                                           GCTTAGTTTAGCATCTTCCAGCTGACAGCGATTGC

  sseK1TT-51CCrev                                          GCAATCGCTGTCAGCTGGAAGATGCTAAACTAAGC

  **Construction of pIZ2136**                              

  sseK1TT-62CCfw                                           CCTCCGGTTAATGCTTAGCCTAGCATC\
                                                           TTTTAGCTGAC

  sseK1TT-62CCrev                                          GTCAGCTAAAAGATGCTAGGCTAAGCATT\
                                                           AACCGGAGG

  **Construction of pIZ2112 and pIZ2137**                  

  sseK1TT-73CCfw                                           GTATTTATGTATCCTCCGGCCAATGCTTAGT\
                                                           TTAGCATC

  sseK1TT-73CCrev                                          GATGCTAAACTAAGCATTGGCCGGAGGATAC\
                                                           ATAAATAC

  **Construction of pIZ2154**                              

  sseK1-73TT-62CCfw                                        CCTCCGGCCAATGCTTAGCCTAGCATCTTT\
                                                           TAGCTGAC

  sseK1-73TT-62CCrev                                       GTCAGCTAAAAGATGCTAGGCTAAGCATTGG\
                                                           CCGGAGG

  ***sseK1 promoter***                                     

  FAMsseK1-500fw                                           TTGGGACAATTACATTATGTTTG

  FAMsseK1+40rev                                           AACAATTAAATGCTCCATACTTAC

  FAMsseK1-300fw                                           CTCGCCATTATAAAATACCTG

  FAMsseK1-1rev                                            CATGATGATTATTAGCACATG

  ***slyB* promoter**                                      

  promslyBdir                                              AGACTTGCCTGTTGCGCAAC

  promslyBrev                                              AAACGCTATTTCAGCATCCC

  ***phoN* promoter**                                      

  promphoNdir                                              AATGCGTGTCAGTCAGGCAC

  promphoNrev                                              TTAGCTACGATCAGTGGTAG
  -----------------------------------------------------------------------------------------------

Plasmids
--------

Plasmids used in this study are listed in **Table [1](#T1){ref-type="table"}**. Plasmid pIZ2115 expressing a transcriptional *sseK1*::*lux* fusion was a derivative of pSB377 (a generous gift from P. Williams, University of Nottingham). To construct this plasmid, DNA from strain 14028 was used as a template for PCR amplification with the primers listed in **Table [2](#T2){ref-type="table"}**. The amplified fragments were digested with *Eco*RI and ligated with *Eco*RI-digested pSB377. To generate point mutations in the *sseK1* promoter, pIZ2095 or pIZ2115 were used as templates for PCR amplification using primer pairs sseK1TT-51CCfw/sseK1TT-51CCrev, sseK1TT-62CCfw/sseK1TT-62CCrev, sseK1TT-73CCfw/sseK1 TT-73CCrev, or sseK1-73TT-62CCfw/sseK1-73TT-62CCrev. Products were digested with 1 μl of *Dpn*I (10 U μl^-1^) for 1 h at 37°C and used to transform *E. coli* DH5α. All constructs were confirmed by DNA sequencing.

Generation of a *sseK1* Mutant
------------------------------

Disruption and replacement of *sseK1* with a Km resistance gene were performed as described previously ([@B19]). Briefly, the Km resistance gene from plasmid pKD4 was PCR amplified with primers sseK1dP1 and sseK1dP2 (**Table [2](#T2){ref-type="table"}**). The PCR product was used to transform the wild-type strain carrying the Red recombinase expression plasmid pKD46.

Construction of *lacZ*, 3xFLAG, and *cyaA*' Chromosomal Fusions
---------------------------------------------------------------

The Km resistance gene from plasmid pKD13 was PCR amplified with primers sseK1P1b and sseK1P4 (**Table [2](#T2){ref-type="table"}**). The PCR product was used to transform the wild-type strain carrying the Red recombinase expression plasmid pKD46. The antibiotic resistance cassette introduced by the gene-targeting procedure described in the previous section was eliminated by recombination using the FLP helper plasmid pCP20 ([@B19]). The FRT site generated by excision of the antibiotic resistance cassette was used to integrate plasmid pCE40 to generate a translational *lac* fusion ([@B20]). Addition of a DNA fragment encoding the 3xFLAG epitope tag at the 3^′^ end of *sseK1* was carried out as described ([@B71]) using primers sseK1P1flag and sseK1P2flag. The protocol to generate a chromosomal *sseK1::cyaA'* translational fusion was recently described ([@B61]).

β-Galactosidase Assays
----------------------

Levels of β-galactosidase were assayed as described ([@B52]), using the CHCl~3~/SDS permeabilization procedure. Bacteria were grown under SPI1 or SPI2-inducing conditions or modifications of these conditions as described in Section "Results."

Antibodies and Immunoblot
-------------------------

*Salmonella* strains were grown under different conditions. Usually, cultures in LB medium were diluted and grown in different media. The bacteria were then pelleted by centrifugation and resuspended in sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) sample buffer. Proteins from the same numbers of bacteria were separated by gradient SDS-PAGE (Mini-PROTEAN TGX precast gels, 4--15%) and electrophoretically transferred to nitrocellulose filters for Western blot analysis using anti-Flag (M2) monoclonal antibodies (1:5000; Sigma), and anti-DnaK (8E2/2) monoclonal antibodies (1:5000; Assay Designs). Goat anti-mouse HRP-conjugated antibodies (1:5000; BioRad) and goat anti-rabbit HRP-conjugated antibodies (1:10000; GE Healthcare) were used as secondary antibodies. Intensities of SseK1-3xFLAG and DnaK bands were quantified using NIH ImageJ 1.42q software.

Virulence Assays in Mice
------------------------

Groups of three 8-weeks-old female BALB/c mice (Charles River Laboratories) were inoculated with a 1:1 ratio of two strains of *S. enterica* serovar Typhimurium: a *ΔsseK1*::Km^r^ null mutant and the wild-type (strain 14028). For oral inoculation, bacterial cultures were grown overnight at 37°C in LB without shaking. For intraperitoneal inoculation, bacteria were grown overnight at 37°C in LB with shaking, diluted into fresh medium (1:100), and grown to an OD~600~ of 0.3--0.6. Oral inoculation was performed by feeding the mice with 25 μl of 0.9% NaCl containing 0.1% lactose and 10^8^ CFU. Intraperitoneal inoculation was performed with 0.2 ml of 0.9% NaCl containing 10^5^ CFU. Bacteria were recovered from spleens 6 days (oral) or 2 days (intraperitoneal) after inoculation and colonies were enumerated on LB and LB with Km (to distinguish mutant and wild-type strains). A competitive index (CI) was calculated as the ratio between the *sseK1* mutant and the wild-type strain in the output (bacteria recovered from spleens) divided by their ratio in the input (initial inoculum). The experimental protocol was approved by the ethical committee of the University of Seville.

Bacterial Infections of Cultured Cells
--------------------------------------

Mammalian cells were plated 24 h before infection in 24-well plates (Thermo Scientific) at 1.5 × 10^5^ cells per well, and incubated at 37°C with 5% CO~2~ in media without antibiotics. For infections under SPI1-inducing (invasive) conditions, bacteria grown overnight in LB-0.3 M NaCl in a tightly closed tube without shaking were added at a multiplicity of infection of 100. For infections of mammalian cells under non-invasive conditions, bacteria were grown in LB for 24 h at 37°C with shaking. Bacteria were centrifuged onto the cell monolayer at 200 g for 5 min and then incubated at 37°C with 5% CO~2~. The cell culture was washed twice with phosphate-buffered saline (PBS) 1 h post-infection (p.i.), overlaid with DMEM containing 100 μg ml^-1^ gentamicin, and incubated for 1 h. The culture was then washed twice with PBS, covered with DMEM with gentamicin 16 μg ml^-1^, and incubated for 2--14 h.

For invasion and proliferation assays, infections were carried out using a 10:1 mix of the *sseK1* mutant and a *trg*::Mu*d*J mutant (wild-type for invasion and intracellular proliferation but Lac^+^ due to the Mu*d*J insertion). CI for invasion and proliferation were calculated as previously described ([@B65]) after plating appropriate dilutions and enumerating white colonies (*sseK1*) and blue colonies (*trg*::Mu*d*J) in LB plates supplemented with 40 μg ml^-1^ 5-bromo-4-chloro-galactopyranoside (X-Gal). For invasion, the input was the initial mix of bacteria used in the infection and the output bacteria recovered 2 h p.i. For intracellular proliferation, bacteria were recovered 1.25 h p.i. (input) and 24 h p.i. (output).

Bioluminescence Assays
----------------------

Bacterial strains were grown under SPI1 or SPI2-inducing conditions. Samples of 150 μl were transferred into white, clear bottom, 96-well plates (Corning) and luminescence and OD~600~ were read using a Synergy HT microplate reader (BioTek). Conditions used for reading luminescence were: read type, endpoint; integration time, 1 s; emission, hole; position, top; sensitivity, 150. To measure luminescence of intracellular bacteria, RAW264.7 cells were plated into white, clear bottom, 96-well plates at 3 × 10^4^ cells per well, and were infected 24 h later with non-invasive bacteria, according to the protocol described in Section "Bacterial Infections of Cultured Cells." Luminescence was measured 2, 4, and 8 h p.i. and the numbers of CFU per well were calculated after incubation with 1% Triton X-100 in PBS for 10 min at 37°C to release bacteria, plating appropriate dilutions in LB with Ap, and counting colonies after 24 h of incubation at 37°C.

Protein Translocation Assay
---------------------------

Following the infections described above, the translocation of the SseK1-CyaA' fusion into the eukaryotic cells was monitored by measuring the levels of cAMP. The infected cells were lysed and the level of cAMP in the lysates was determined using a colorimetric direct cAMP enzyme immunoassay kit (Arbor Assays) according to the manufacturer's instructions.

Protein Purification and Phosphorylation
----------------------------------------

His~6~-PhoP protein was produced and purified as previously described ([@B23]) with some modifications ([@B13]). For binding assays, *S. enterica* His~6~-PhoP was phosphorylated with acetyl phosphate as previously described ([@B68]) with modifications. Briefly, His~6~-PhoP was incubated in 20 μl of phosphorylation buffer (50 mM Tris-HCl pH 7.5, 50 mM KCl, 10 mM MgCl~2~) containing 10 mM acetyl phosphate (Sigma-Aldrich) for 1 h at 37°C.

Electrophoretic Mobility Shift Assay (EMSA)
-------------------------------------------

DNA fragments used for the PhoP binding assay were amplified by PCR using *Salmonella* 14028 as a template. The primers, listed in **Table [2](#T2){ref-type="table"}**, were labeled with 6-carboxyfluorescein (FAM). PCR amplification rendered fragments of 281, 355, and 540 (or 300) bp for *phoN*, *slyB,* and *sseK1* promoters, respectively. The binding assay was carried out as previously described ([@B68]) with modifications. Briefly, a solution of 5 nM of FAM-labeled DNA and 0, 0.125, 0.25, 0.5, 1, and 2 μM of phosphorylated His~6~-PhoP was prepared in binding buffer (50 mM Tris-HCl pH 8.0, 50 mM KCl) in a total volume of 20 μl and incubated for 30 min at room temperature. Protein-DNA complexes were subjected to electrophoresis at 4°C in a 6% non-denaturing acrylamide:bisacrylamide (29:1) gel in 0.5X Tris-borate-EDTA buffer. Images were acquired using a Fujifilm FLA-5100 system.

Statistical Analysis
--------------------

Student's *t*-test was used to analyze differences in β-galactosidase activities and light emission. This test was also used to analyze every CI against the null hypothesis that the mean is not significantly different from 1. *P* values of 0.05 or less were considered significant.

Results
=======

Contribution of SseK1 to Virulence in Mice
------------------------------------------

The role of SseK1 and SseK2 in virulence was previously evaluated by infecting BALB/c mice with *sseK1, sseK2* or*sseK1 sseK2* mutants, but no attenuation was detected using a time to death assay after intraperitoneal infections ([@B41]). More recently, a sensitive method, the CI, revealed significant attenuation of the *sseK1 sseK2 sseK3* triple mutant and of the *sseK1 sseK2* double mutant, but no attenuation of the *sseK3* single mutant, after oral infections ([@B8]). These results prompted us to analyze the specific contribution of SseK1 to *Salmonella* virulence. An *sseK1* null mutant was generated and the CI for this single mutant compared to the wild-type strain (*S. enterica* serovar Typhimurium strain 14028). Significant attenuation (*P* \< 0.05) was observed both after intraperitoneal and after oral infections of BALB/c mice (**Figure [1A](#F1){ref-type="fig"}**). Specific contribution of SseK1 to invasion and intracellular proliferation was assessed calculating the CI of the *sseK1* mutant against the *trg*::Mu*d*J strain \[wild-type for invasion and intracellular proliferation ([@B65])\] in a variety of mammalian cell types: HeLa (human epithelial), NRK-49F (rat fibroblasts), RAW264.7 (murine macrophages), Cos-7 (monkey fibroblasts), 3T3 (murine fibroblasts), J774.A1 (murine macrophages), and Caco2 (human epithelial). No significant defect was detected for this mutant (*P* \> 0.05; **Figures [1B,C](#F1){ref-type="fig"}**). Together, the results shown in this section suggest that SseK1 is necessary for full virulence of *Salmonella* in mice but that it does not contribute specifically to invasion or intracellular proliferation, at least in the cell types and under the conditions tested.

![**Competitive index (CI) analysis for an *sseK1* null mutant. (A)** Graphical representation of CI analysis of a strain carrying a mutation in *sseK1* after intraperitoneal (ip) and oral mice infections. **(B)** Analysis of invasion of the *sseK1* mutant in mixed infections with a *trg*::Mu*d*J mutant used as the wild-type strain. **(C)** Analysis of intracellular proliferation of the *sseK1* mutant in mixed infections with a *trg*::Mu*d*J mutant used as the control strain. The CIs are the means from three infections. Error bars represent the SD. wt, wild-type strain. Asterisks denote that the CIs are significantly different from 1 for a *t*-test *P* value \< 0.05.](fmicb-06-00396-g001){#F1}

Synthesis and Translocation into Mammalian Cells of SseK1 Under SPI1 and SPI2 Inducing Conditions
-------------------------------------------------------------------------------------------------

Although expression and secretion to culture media of SseK1 was detected under SPI1 and SPI2-inducing conditions, this *Salmonella* effector was described as translocated into human epithelial HeLa cells specifically through the T3SS2 ([@B41]). These previous results were obtained based on SseK1-2HA and SseK1-CyaA' fusions expressed from a plasmid. To carry out a more detailed analysis of the expression of *sseK1,* we constructed a chromosomal *lacZ* translational fusion in the native *sseK1* locus. This fusion permits quantification of the physiological levels of expression of this gene by measuring β-galactosidase activities (see Materials and Methods). As seen in **Figure [2A](#F2){ref-type="fig"}**, *sseK1* was expressed under SPI1-inducing conditions (LB, 0.3 M NaCl, without aeration) but its expression was significantly higher (*P* \< 0.01) under SPI2-inducing conditions (LPM, pH 5.8, high aeration). Variants of these conditions were tested to detect relevant factors influencing the expression of *sseK1*. Changes in osmolarity in the SPI1-inducing medium had little but significant impact (*P* \< 0.01 or 0.05; **Figure [2B](#F2){ref-type="fig"}**), and the maximum expression in this medium was obtained with the original NaCl concentration (0.3 M). Hypoxia did not appear to be an important factor in the expression of *sseK1* but butyrate, a fermentation product found in the intestine that is known to downregulate SPI1 genes, caused a significant repression (*P* \< 0.01) of *sseK1* expression (**Figure [2C](#F2){ref-type="fig"}**). Interestingly, although the low Mg^++^ concentration that is present in the medium used to induce SPI2 (LPM) was a factor contributing to expression of *sseK1*, the acidic pH of the same medium had a negative impact (**Figure [2D](#F2){ref-type="fig"}**) and the highest expression was observed in LPM with low Mg^++^ concentration at pH 8.4 (*P* \< 0.01). A general conclusion of these experiments is that expression of *sseK1* is not restricted to SPI1- or SPI2-inducing conditions resulting in coexpression of this gene with both islands.

![**Expression of *sseK1* in different culture media.** β-Galactosidase activities were measured from overnight cultures of a *Salmonella enterica* strain carrying a chromosomal *sseK1::lacZ* translational fusion. **(A)** Bacteria were incubated overnight at 37°C in LB with 0.3 M NaCl without shaking (SPI1) or in LPM with shaking (SPI2). **(B)** Different concentrations of NaCl were used to test the role of osmolarity on *sseK1* expression under SPI1-inducing conditions.**(C)** The effects of pH, oxygen limitation and butyrate on *sseK1* expression were tested in LB. **(D)** Activities were measured after growth in LPM with different pH and Mg^++^ concentrations, as indicated. Means and SD from three independent β-galactosidase measurements are shown. Statistical significance is shown by asterisks representing *t*-test *P* values: ^∗^*P* \< 0.05; ^∗∗^*P* \< 0.01. C: reference for statistical comparison.](fmicb-06-00396-g002){#F2}

The results shown above are compatible with translocation of SseK1 through T3SS1 and T3SS2. A detailed analysis of this possibility was carried out using two kinds of SseK1-CyaA' fusions: the first one was prepared in a plasmid and its expression was driven by a constitutive promoter; the second one was generated in the chromosome under the control of the native promoter. In both cases the whole SseK1 protein was fused to the catalytic domain of the calmodulin-dependent adenylate cyclase from *Bordetella pertussis*. *Salmonella* strains (wild-type and mutants lacking T3SSs) expressing these fusions were used to infect three mammalian cell types: human epithelial HeLa cells, murine RAW264.7 macrophages and rat NRK-49F fibroblasts. Translocation of the fusion into host cells was tested 1, 2, 4, 8, and 16 h p.i. and was detected as an increase in cAMP concentration in the cell culture (**Figure [3](#F3){ref-type="fig"}**). All the infections were carried out using invasive bacteria (grown under SPI1-inducing conditions) except long infections (4--16 h) of RAW cells to prevent rapid macrophage pyroptosis induced by invasive bacteria ([@B21]). Interestingly, different patterns of translocation were observed depending on the host cell and on the fusion. The main conclusions are: (i) Translocation of SseK1 at short times (1 and 2 h p.i.) is only observed when the fusion is constitutively expressed from a plasmid (**Figures [3A,C,E](#F3){ref-type="fig"}**) and is dependent on T3SS1 in the three cell types. (ii) When *sseK1* is expressed from its own promoter (**Figures [3B,D,F](#F3){ref-type="fig"}**), translocation of SseK1 starts at 4 h p.i. in epithelial cells and fibroblasts, and at 8 h p.i. in macrophages. Under these conditions, translocation into HeLa cells depends on T3SS1, translocation into RAW cells depends on T3SS2, and translocation into NRK cells occurs through both systems.

![**Translocation of SseK1 into mammalian cells.** Human epithelial HeLa cells **(A,B)**, RAW264.7 murine macrophage-like cells **(C,D)** and NRK-49F normal rat kidney fibroblasts **(E,F)** were infected with derivatives of *S. enterica* serovar Typhimurium 14028 (wild-type, wt, ΔSPI1, ΔSPI2 and ΔSPI1 ΔSPI2 strains) carrying a plasmid expressing an SseK1-CyaA' fusion from a constitutive promoter **(A,C,E)** or a chromosomal SseK1-CyaA' fusion expressed under the native *sseK1* promoter **(B,D,F)**. Bacteria were grown under SPI1-inducing conditions for most infections. Non-invasive bacteria were used specifically for infections of RAW264.7 cells for 4, 8, and 16 h. To detect translocation, the level of cAMP was measured 1, 2, 4, 8, and 16 h p.i. Means and SD from triplicate experiments are represented.](fmicb-06-00396-g003){#F3}

SsrB Independent Regulation of *sseK1* by PhoQ/PhoP
---------------------------------------------------

We took advantage of the chromosomal *sseK1::lacZ* fusion to look for genetic factors controlling *sseK1* expression. We tested the effect of mutations in genes encoding important virulence regulators: HilA, HilD, SsrB, PhoP, RcsB, and Dam. HilA and HilD are positive regulators of SPI1 ([@B3]; [@B62]). SsrB is the main positive regulator of the expression of SPI2 ([@B17]). Both islands are regulated by PhoP, that positively regulates SPI2 through SsrB and negatively regulates SPI1 through HilA ([@B4]; [@B6]). RcsB represses SPI1 through HilD ([@B55]; [@B44]). Dam is an adenine methylase that activates SPI1 through HilD ([@B45]). In addition to null mutations in all these genes, the point mutations *phoQ24* and *rcsC54* were also used. These mutations result in constitutive activation of the two-component system PhoQ/PhoP and of the phosphorelay system RcsC/RcsD/RcsB, respectively. The level of expression of *sseK1::lacZ* was measured in liquid bacterial cultures grown under SPI1 (**Figure [4A](#F4){ref-type="fig"}**) or SPI2 (**Figure [4B](#F4){ref-type="fig"}**) inducing conditions. The results suggest that PhoP is a positive regulator of *sseK1* expression since a significant decrease in expression was observed in a *phoP*-null mutant under SPI2 inducing conditions (*P* \< 0.01). This conclusion is confirmed by the positive effect of the activating mutation *phoQ24* on *sseK1* expression under SPI1-inducing conditions (*P* \< 0.05). We also assessed the effect of the *phoP* mutation on SseK1 at the protein level using a chromosomal 3xFLAG fusion (**Figure [4C](#F4){ref-type="fig"}**). The effect was more dramatic at this level suggesting some kind of postranslational regulation in addition to the modulation of transcription that is expected for PhoP. No effect was detected for mutations affecting the other regulators that were tested in these assays, including SsrB. Lack of SsrB had no significant impact on *sseK1* expression even in a *phoQ24* background (**Figure [4D](#F4){ref-type="fig"}**), providing evidence for SsrB-independent upregulation of *sseK1* by the PhoQ/PhoP system.

![**Positive regulation of the expression of *sseK1* by the PhoQ/PhoP system.** β-Galactosidase activities were measured from SPI1-inducing **(A)** and SPI2-inducing **(B)** cultures of several *S. enterica* serovar Typhimurium strains: wild-type 14028 (wt), null mutants (*hilA, hilD, ssrB, rcsB*, and *dam*), and mutants with constitutive activation of the PhoQ/PhoP system and the Rcs system, respectively (*phoQ24* and *rcsC54*), carrying an *sseK1::lacZ* translational fusion. The role of SsrB in the regulation by PhoP was investigated in a double mutant *phoQ24 ssrB*. Means and SD from three independent β-galactosidase measurements are shown. The effect of the PhoQ/PhoP system **(C)** and of SsrB **(D)** on *sseK1* expression at the protein level was assessed by immunoblot analysis using strains expressing SseK1-3xFLAG. A monoclonal anti-FLAG antibody was used to detect the fusion protein and a polyclonal anti-DnaK antibody was used to get a loading control. Representative gels are shown together with quantification of bands (SseK1/DnaK ratio) from duplicate gels. Statistical significance of the differences between wt and mutant strains is shown by asterisks representing *t*-test *P* values: ^∗^*P* \< 0.05; ^∗∗^*P* \< 0.01.](fmicb-06-00396-g004){#F4}

Direct Regulation of *sseK1* Expression by PhoP
-----------------------------------------------

Next, we reasoned that since PhoP regulates *sseK1* in an SsrB-independent manner, it could be a direct regulator of this gene. To test this possibility, we decided to analyze the promoter region of *sseK1* looking for a putative PhoP-binding site. According to a previous global analysis carried out on *S. enterica* serovar Typhimurium strain SL1344 ([@B40]), the transcriptional start site of *sseK1* is a T located 40 nucleotides upstream of the translational start codon. Visual inspection revealed the presence of putative -10 and -35 consensus motifs for σ70-dependent transcription with the appropriate spacing (**Figure [5A](#F5){ref-type="fig"}**). In addition, a sequence resembling the PhoP box consensus motif (T/G)GTTTA-NNNNN-(T/G)GTTTA (where N is any nucleotide), was found at position -75/-59 relative to the transcriptional start site. Another putative half box, less similar to the expected consensus, was located at -53/-48. The role of this region in driving the transcription of *sseK1* was tested using two different promoter probe plasmids: pIC552 and pSB377. A DNA fragment containing the promoter and 5^′^ untranslated regions of *sseK1*, from -500 to +40, was cloned into these plasmids to generate a *lacZ* transcriptional fusion (**Figure [5B](#F5){ref-type="fig"}**) and a bioluminescent *lux* transcriptional fusion (**Figure [5C](#F5){ref-type="fig"}**), respectively. Expression of the fusions in wt and *phoP* backgrounds indicated that the cloned region contained the signals necessary for expression and PhoP-mediated regulation of *sseK1*. To test the relevance of the putative PhoP binding sites, three independent mutants were obtained in the *lux* fusion plasmid. Each mutant was constructed by exchanging the conserved TT motif in the middle of a putative half PhoP box sequence for CC (**Figure [5A](#F5){ref-type="fig"}**). Whereas mutations at positions -51/-50 had no effect on the expression of the fusion, alteration of the -62/-61 or the -73/-72 motifs completely abrogated PhoP regulation of the fusion under SPI1 (**Figure [5D](#F5){ref-type="fig"}**) and SPI2-inducing conditions (**Figure [5E](#F5){ref-type="fig"}**). These results suggest that the region -75/-59 constitutes a complete PhoP binding box.

![**Identification of a PhoP box in the promoter of *sseK1*. (A)** Analysis of the promoter region of *sseK1*. The sequence surrounding the transcriptional start site (+1) is shown. The start of the coding sequence, the putative ribosomal binding site and the consensus sequences for σ^70^-dependent transcription (-10 and -35) are indicated. Putative PhoP-binding motifs are marked in pink and a putative PhoP-box is underlined with an arrow. A fragment of DNA containing the promoter region and 5^′^ untranslated region of *sseK1* (-500/+40) was inserted into plasmid pIC552 to generate a *lacZ* transcriptional fusion **(B)** and into plasmid pSB377 to generate a *luxCDABE* transcriptional fusion **(C)**. These plasmids and the corresponding original empty vectors were introduced into *S. enterica* serovar Typhimurium strain 14028 (wt) or a *phoP*-null mutant, and β-galactosidase activities or luminescence, respectively, were measured in cultures grown to stationary phase in liquid LPM at pH 5.8. Luminescence was also measured from the wt, *phoP* and *phoQ24* strains carrying derivatives of pSB377 with the promoter region of *sseK1* or variants with the indicated mutations and grown under SPI1 **(D)** or SPI2 **(E)** inducing conditions. RLU: relative light units.](fmicb-06-00396-g005){#F5}

Finally, an electrophoretic mobility shift assay was used to analyze the binding of PhoP to the promoter of *sseK1*. The promoters of *slyB* and *phoN* were used as positive and negative controls, respectively. Phosphorylated His~6~-PhoP and PCR-amplified DNA fragment containing the relevant promoters were used in these experiments. As seen in **Figure [6A](#F6){ref-type="fig"}**, PhoP was able to bind to the *slyB* and *sseK1* promoters and no binding was observed to the *phoN* promoter. In addition, mutations at positions -61/-62 and -72/-73, prevented PhoP binding (**Figure [6B](#F6){ref-type="fig"}**). These results provide additional support to the hypothesis that the region -75/-59 is a PhoP binding box.

![**Direct interaction of phosphorylated PhoP with the promoter region of *sseK1*.** Purified His~6~-PhoP was phosphorylated *in vitro* with acetyl phosphate. **(A)** DNA fragments containing the promoter regions of *sseK1* (-500/+40), *phoN* and *slyB* were PCR amplified using fluorochrome-labeled primers and incubated with the indicated concentrations of phosphorylated His~6~-PhoP (PhoP-P). Electrophoretic mobility shift assays were used to detect binding. **(B)** DNA fragments containing the promoter regions of *sseK1* (-300/-1) wild-type (wt) or with mutations T-- \> C at positions -73, -72, -62 y -61 (PhoP box mutant) were PCR amplified using fluorochrome-labeled primers and incubated with the indicated concentrations of phosphorylated His~6~-PhoP (PhoP-P). Electrophoretic mobility shift assays were used to detect binding.](fmicb-06-00396-g006){#F6}

Expression of *sseK1* Inside Macrophages
----------------------------------------

We took advantage of the *sseK1::lux* transcriptional fusion described above to study expression of *sseK1* during infection of RAW264.7 macrophages. *Salmonella* strains expressing this fusion were used to infect cultures of these cells in 96-well plates. As seen in **Figure [7](#F7){ref-type="fig"}**, luminescence per wild-type CFU was increased 4 and 8 h p.i. compared to 2 h p.i., suggesting that *sseK1* expression is induced, together with T3SS2, in response to intravacuolar signals. In contrast, intracellular induction was not observed in a *phoP* null mutant, giving additional support to the conclusion that PhoP is a positive regulator of the expression of *sseK1*.

![**Intracellular PhoP-dependent expression of *sseK1*.** Two strains of *S. enterica* serovar Typhimurium (wild-type, wt, and *phoP* mutant) carrying a plasmid expressing an *sseK1::luxCDABE* transcriptional fusion (pSB377-*sseK1*\[-500/+40\]) were grown for 24 h in LB at 37°C with aeration (non-invasive conditions). These bacteria were used to infect RAW264.7 murine macrophage-like cells and luminescence produced by intracellular bacteria was measured 2, 4, and 8 h p.i.](fmicb-06-00396-g007){#F7}

Discussion
==========

Although the functions of the members of the SseK family of T3SS effectors are unknown, their amino acid sequence similarities suggested some redundancy in their functions. In previous studies, virulence attenuation was only shown for the triple *sseK1 sseK2 sseK3* or the double *sseK1 sseK2* mutants. The results presented here, however, clearly show that SseK1 is important in itself during the systemic phase of the infection in the mouse model, since a single *sseK1* mutant is significantly attenuated after oral and intraperitoneal infections (**Figure [1](#F1){ref-type="fig"}**). In addition, our efforts to detect secretion of SseK2 and SseK3 were unsuccessful, probably due to the low expression levels of these proteins under the conditions tested (data not shown). Our results also suggest that SseK1 is not necessary for invasion or intracellular proliferation in seven different mammalian cell lines. This is in agreement with previous attempts that were unable to find a phenotype following infection of HeLa, Caco2 or RAW264.7 cells ([@B41]; [@B8]; [@B10]). However, one of these reports showed a 60% reduction in the replication index of the triple mutant *sseK1 sseK2 sseK3* inside RAW264.7 macrophages ([@B10]). The discrepancy between results obtained in different laboratories may be a consequence of differences in experimental details including specific *Salmonella* strains used and multiplicity of infection.

SseK1 was initially described as a T3SS2 effector in HeLa cells ([@B41]; [@B8]). Here, we carried out a detailed analysis of translocation of this effector using three host cell lines, from three different mammalian species, and two different CyaA' fusions (**Figure [3](#F3){ref-type="fig"}**). Our results suggest several conclusions and comments: (i) A first general conclusion is that SseK1 can be secreted through T3SS1 and T3SS2, although with different kinetics depending on the host cell type. Hence, the examination of as many host cell types as possible is essential to fully understand the function of T3SS effectors. (ii) Translocation at short time p.i. (1--2 h) was T3SS1-dependent but was only observed when the SseK1-CyaA' fusion was expressed from a constitutive promoter in a plasmid. This result suggests that under physiological conditions (expression from its own promoter in the chromosome) SseK1 is not synthetized at sufficient level to allow detectable translocation before invasion of the host cell. It also indicates that the use of chromosomal fusions is more reliable in order to get conclusions about the conditions necessary for translocation of T3SS effectors. (iii) Translocation into epithelial HeLa cells was dependent on T3SS1, since it was not detected in a mutant lacking this system (**Figure [3B](#F3){ref-type="fig"}**). This result may be partially explained by the fact that the trigger mechanism mediated by T3SS1 is necessary for the invasion of these cells. As a consequence, translocation from internalized bacteria through T3SS2, if it existed, would not be detected using the ΔSPI1 mutant. (iv) Translocation into NRK fibroblasts, although T3SS1-dependent at 4 h p.i., appears to occur through both systems at 8 and 16 h p.i., since simultaneous inactivation of T3SS1 and T3SS2 is necessary to abolish the increase in cAMP (**Figure [3F](#F3){ref-type="fig"}**). Detection of T3SS2-dependent translocation using the T3SS1 mutant is possible in this model because invasion of fibroblasts can take place using a multiplicity of entry mechanisms ([@B1]). (v) Translocation of SseK1 into macrophages infected with non-invasive bacteria was T3SS2-dependent and was detected 8 and 16 h p.i., but not 4 h p.i. (**Figure [3D](#F3){ref-type="fig"}**). This is similar to the timing observed for T3SS2-dependent SseK1 translocation into fibroblasts infected with invasive bacteria and suggests that this system begins to be functional between 4 and 8 h after internalization in both cell types. The results obtained in RAW cells also suggest that non-invasive phagocytized bacteria are unable to induce T3SS1 inside these cells.

These results fit well into the context of a previous report showing simultaneous expression of T3SS1 and T3SS2 inside HeLa cells ([@B35]). This initially surprising coexpression was explained by the existence of two subpopulations of *Salmonella* in epithelial cells: a T3SS2-induced intravacuolar subpopulation and a T3SS1-induced cytosolic subpopulation ([@B39]). Cytosolic *Salmonella* are also detected in fibroblasts and macrophages, although the permissiveness for *Salmonella* survival and replication in the cytosol is dependent upon the cell type (reviewed in [@B38]).

In this study, we also used a combination of *lac*, 3xFLAG and *lux* fusions to analyze the environmental conditions and the genetic factors involved in the regulation of the expression of *sseK1*. Maximal expression in rich medium was obtained with 0.3 M NaCl and modest repression was observed with lower and higher salt concentrations (**Figure [2B](#F2){ref-type="fig"}**). Two additional factors that decreased expression of *sseK1* in rich medium were low pH and butyric acid (**Figure [2C](#F2){ref-type="fig"}**), a major short chain fatty acid produced in the intestine by anaerobic bacterial fermentation. This organic acid is known to repress SPI1 and other T3SS1-related genes ([@B42]; [@B24]; [@B28]; [@B12]). Expression in a minimal medium mimicking intravacuolar conditions (LPM) was higher than in rich medium (**Figure [2A](#F2){ref-type="fig"}**). However, acidic pH, which is one of the environmental cues used to induce SPI2, had a negative impact on the expression of *sseK1* also in minimal medium (**Figure [2D](#F2){ref-type="fig"}**). These data, together with translocation data shown in **Figure [3](#F3){ref-type="fig"}** and discussed above, suggest that expression of *sseK1* could be partially repressed during passage through the stomach and the gut, but it would be induced after invasion of host cells and specially after release into the cytosol of non-phagocytic cells.

Among the SPI1 and SPI2 regulators that we tested, only the PhoQ/PhoP two-component regulatory system had a significant effect on the expression of *sseK1* (**Figure [4](#F4){ref-type="fig"}**). PhoQ is a membrane protein that activates PhoP in response to low Mg^++^ concentration ([@B27]; [@B54]). PhoP is a transcription factor that regulates expression of about 3% of the *Salmonella* genes ([@B53]). These genes are involved in the control of physiological and virulence functions. Positive regulation of *sseK1* by this system is consistent with the effect of Mg^++^ concentrations on its expression (**Figure [2D](#F2){ref-type="fig"}**).

The results obtained at the protein level with an SseK1-3xFLAG fusion are consistent with a previous report using a 2xHA fusion ([@B41]) and indicated that SseK1 was undetectable in a *phoP* null background. Our results also showed that this dramatic effect is observed specifically under SPI2-inducing conditions (**Figure [4C](#F4){ref-type="fig"}**), suggesting that under SPI1-inducing conditions there are other unidentified factors allowing synthesis of SseK1 in the absence of PhoP. The comparison between the results obtained at the protein level (Western blot in **Figures [4C,D](#F4){ref-type="fig"}**) and the results obtained using a chromosomal *sseK1::lacZ* translational fusion (β-galactosidase activities in **Figure [4B](#F4){ref-type="fig"}**) also suggests an indirect posttranslational effect in addition to the transcriptional effect that is expected for a regulator like PhoP.

Whereas PhoQ/PhoP is considered an ancestral regulatory system that is conserved in enteric bacteria and senses Mg^++^ concentrations, the two-component system SsrA/SsrB is *Salmonella*-specific and is activated by acidic pH ([@B49]; [@B56]). SsrB is necessary for the expression of T3SS2 and some of its effectors that are encoded outside SPI2 ([@B58]; [@B17]; [@B36]; [@B73]). Since PhoP controls expression of the response regulator SsrB at the transcriptional level and of the sensor SsrA at a posttranscriptional level ([@B6]), it also indirectly regulates expression of SsrB-regulated genes. However, our epistasis analysis combining an *ssrB* null mutation with a *phoQ24* activating mutation (**Figure [4](#F4){ref-type="fig"}**) clearly showed that the effect of PhoP on *sseK1* was SsrB-independent, which is consistent with the induction of *sseK1* expression by low Mg^++^ concentrations but not by low pH. This result also suggested the possibility of direct regulation of *sseK1* by PhoP. Two lines of evidence support this hypothesis: (i) PhoP regulation of a *lux* transcriptional fusion was abrogated by mutations in a putative PhoP-box that was detected in the promoter region of *sseK1* (**Figure [5](#F5){ref-type="fig"}**). (ii) Binding of PhoP to the promoter region of *sseK1* was confirmed by EMSA analysis (**Figure [6A](#F6){ref-type="fig"}**). In addition, mutation of the putative PhoP-box significantly reduced binding (**Figure [6B](#F6){ref-type="fig"}**).

The bioluminescent fusion used here showed great sensitivity and was used to demonstrate *in vivo* PhoP-dependent induction of *sseK1* inside macrophages (**Figure [7](#F7){ref-type="fig"}**), giving stronger support to the conclusions obtained using a culture medium (LPM) that imitates intravacuolar conditions (**Figure [4](#F4){ref-type="fig"}**). This fusion could also be, in principle, useful for future experiments regarding the study of expression of *sseK1* inside animal models.

In summary, our results suggest that the T3SS effector SseK1 is a virulent factor that responds to a complex array of environmental signals. Expression of *sseK1* is directly activated by PhoP under SPI2-inducing conditions and, probably, by other unknown regulators under SPI1-inducing conditions. In response to these signals and regulators SseK1 is expressed and translocated through both T3SS1 and T3SS2 when *Salmonella* is inside the host cell. Additional experiments will be necessary to understand the specific role of SseK1 during infections.
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